“P.S. To ask once more, does anyone know how to get the stock ownership breakdown of BIEL's insiders (i.e., company officials)? That bit of info might give us a clue to what's going on here.”
The answers to your 2 questions are very simple and found in various places, with much digging. Simply put, there is much quiet interest in BIEL and the numerous positive effects of ActiPatch on both chronic and acute pain management globally. Think of the number of countries, number of knowledgeable people, opioid epidemic, deep pockets and the often posted facts that BIEL stock is very closely held......
Those holding large, very large quantities of stock do not wish to reveal specific details, but think of the facts in the U.S.: 2 OTC FDA clearances for foot and knee; FDA asks specifically for a small 3rd trial; BIEL immediately complies and submits the very positive back trial results; NHS-England and Wales, adds ActiPatch to theIr Insured product Tariff April 1; NHS-Scotland and Ireland add to theIr Tariffs April 15; B.Braun announces, also April 15 +-, huge expansion of its ActiPatch program by adding surgical day surgery clinics and the provision of a prescription to post-op surgical patients for 8 ActiPatches covered by NHS on discharge; the silence of BIEL; and the subtle disclosures in the recent CEO letter to shareholders; all pose the answers for you, in the form of a third question- do you hear the Tsunami warning sirens yet?
BIEL has one TOL mission currently; co-Branding deals, USA - now think multi-national.....
And, guaranteed, those outsiders holding large quantities of BIEL shares do not want anyone to know precise details, as is their right. With all that has been revealed, in the most helpful of ways, only an idiot could not reach a conclusion and you are far from an idiot! Oh sure, there are those that frantically ‘need to know’ ad nauseum, but the wisest wait patiently for landfall......
YKW - you add whatever word works for you, I’m done, but I also know when.....because it is so clear....
Sleepin like a baby......Go BIEL
News 
Market Data 
Discover 
